Condition: Degenerative Disc Disease · Lumbar Disc Disease · Spine Disease · Sponsor: Locate Bio Pty Ltd
The objective of this study is to evaluate the safety and effectiveness of LDGraft (investigational device) compared to 100% human tissue product allograft bone (control) when applied in an ALIF procedure in the treatment of patients with lumbar degenerative disc disease (DDD).
This description comes directly from the study's public registry record.
Robyn Cochrane · +44 (0)115 784 0041 · rcochrane@locatebio.com
Always discuss trial participation with your own doctor first.
| Orthopaedics NorthEast | Fort Wayne, Indiana, United States | Recruiting |
| Pinehurst Surgical Clinic | Pinehurst, North Carolina, United States | Recruiting |
| Newcastle Private Hospital | Newcastle, New South Wales, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06462729